Edwards Lifesciences acquires Harpoon Medical for $100M

Edwards Lifesciences acquired Harpoon Medical, a medical technology company developing beating-heart repair for mitral regurgitation, for $100 million in cash at closing on December 1, 2017, with potential milestone payments up to $150 million over 10 years.

“Edwards Lifesciences Corporation today announced the acquisition of Harpoon Medical, Inc., a privately held medical technology company pioneering beating-heart repair for degenerative mitral regurgitation (DMR).”prnewswire.com

• 1 source
• prnewswire.comEdwards Acquires Harpoon MedicalEdwards Lifesciences CorporationDec 6, 2017

Summarized from public sources; check the original articles before acting on it.